Placebo-controlled, double-blind, prospective, randomized study of the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID study group
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: R. Arnold, H. Müller, C. Schade-Brittinger, A. Rinke, K. Klose, P. Barth, M. Wied, C. Mayer, B. Aminossadati, PROMID Study Group
Institution: Philipps University of Marburg
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: octreotide LAR, long-acting somatostatin analogue, metastatic neuroendocrine tumors, midgut neuroendocrine tumors, tumor progression, time to tumor progression, stable disease, antiproliferative activity, gastroenteropancreatic neuroendocrine tumors, overall survival, symptom management, interim analysis
Open Access status: closed
OpenAlex ID: W4253360717
